I am encountering difficulties in transfecting PMO (phosphorodiamidate morpholino oligomer) with endoporter into the C2C12 cell line. Furthermore, transfecting the C2C12 cell line with PMO hybridized with a complementary strand using Lipofectamine does not work as well. I would appreciate any suggestions on how to address these challenges.